Skip to content

Clinical trials

Recurrence trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Country / region: Italy Clear all

289 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20031
20043
20059
20069
20076
20084
200910
201011
20115
201216
20135
201412
201512
201616
201717
201817
201917
202015
202118
202216
202317
202411
202520
202610

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed143
Recruiting47
Terminated37
Active, not recruiting32
Unknown status20
Not yet recruiting3
Enrolling by invitation2
Withdrawn2
Temporarily not available1
Suspended1
No longer available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene28
Novartis Pharmaceuticals20
AbbVie10
AstraZeneca9
Amgen7
Fondazione Italiana Linfomi - ETS7
Fred Hutchinson Cancer Center7
Bristol-Myers Squibb6
Gruppo Italiano Malattie EMatologiche dell'Adulto5
Hoffmann-La Roche5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence289
Multiple Myeloma42
Lymphoma, Non-Hodgkin33
Neoplasms29
Lymphoma, Large B-Cell, Diffuse27
Leukemia, Myeloid, Acute24
Lymphoma24
Precursor Cell Lymphoblastic Leukemia-Lymphoma23
Leukemia, Lymphocytic, Chronic, B-Cell22
Lymphoma, Follicular22

Trials

Showing 76 to 100 of 289. Each trial links to its page on Pharma Observatory.

189 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.